NIH, Columbia Team Employs Drug and Gene Screens to Find Antimalarial Candidates

Researchers from the National Institutes of Health and Columbia University screened more than 2,800 compounds in 61 Plasmodium falciparum lines, identifying potential anti-malarial agents and using genetic approaches to find loci related to treatment response differences in the malaria parasite.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.